Spondyloarthritis

FDA Approves Ixekizumab for Treating Active Ankylosing Spondylitis

September 23, 2019 • By Michele B. Kaufman, PharmD, BCGP

Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA

September 17, 2019 • By Lara C. Pullen, PhD

No Gain with Pain: Exercise & Physical Function in Patients with Rheumatic Disease

September 9, 2019 • By Jason Liebowitz, MD

Updates to Axial Spondyloarthritis Guideline

September 5, 2019 • By Carina Stanton

Peripheral Arthritis & Recent Onset Axial SpA: 5-Year Results from the DESIR Cohort

July 29, 2019 • By Lara C. Pullen, PhD

Ankylosing Spondylitis Patients Report Improved Quality of Life with Bimekizumab

July 8, 2019 • By Michele B. Kaufman, PharmD, BCGP

Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

June 27, 2019 • By Arthritis & Rheumatology

A New Treatment for Axial Spondyloarthritis?

A New Treatment for Axial Spondyloarthritis?

June 17, 2019 • By Mary Beth Nierengarten

Peripheral Manifestations of Spondyloarthritis

May 29, 2019 • By Lara C. Pullen, PhD

Tracking Bone Deterioration in Patients with Ankylosing Spondylitis

April 2, 2019 • By Lara C. Pullen, PhD